Exploiting the antidiabetic properties of incretins to treat type 2 diabetes mellitus: glucagon-like peptide 1 receptor agonists or insulin for patients with inadequate glycemic control?

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples